{
    "nctId": "NCT00606970",
    "briefTitle": "Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy",
    "officialTitle": "Assessment of the Safety of Dietary Supplement Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy",
    "overallStatus": "WITHDRAWN",
    "conditions": "Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Change in self-rated symptoms and assessed signs",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Eligible subjects have given written informed consent prior to participation\n* They must have a life expectancy of greater than 6 months\n* They must have biopsy confirmed primary breast, colon or lung cancer\n* They are receiving standard chemotherapy in accordance with American Society Clinical Oncology (ASCO) standards and have at least one month remaining in their chemotherapy course\n* They must have an Eastern Cooperative Oncology Group (ECOG) performance status \\< 2 and are being treated as outpatients.\n* Subjects must be between the ages of 18 to 75 years of age.\n* Subjects must be able to communicate in English.\n\nExclusion Criteria:\n\n* Have received radiotherapy within the last 4 weeks\n* Have acute gastrointestinal problems e.g. acute gastrointestinal infection, gastric or duodenal ulcer, history of bowel obstruction, diverticulitis, Crohn's disease, ulcerative colitis, or chronic diarrhea\n* Presence or clinical evidence of CNS metastases\n* Receiving corticosteroids\n* Have severe concomitant disease\n* Have severe dysphagia, esophagitis or xerostoma",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}